Condition
Systemic Arterial Hypertension
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04861727Not ApplicableCompletedPrimary
Use of Technology to Optimize Hypertension Treatment in Elderly People in Primary Care
NCT05202067Not ApplicableCompleted
Impact of Pharmaceutical Education on Medication Adherence
NCT03729323Not ApplicableCompleted
Motivational Interviewing in the Control of Arterial Hypertension and Type 2 Diabetes Mellitus
NCT03955159Not ApplicableUnknownPrimary
Effects of Probiotic Supplementation in Hypertensive Women on Menopause
NCT01173029CompletedPrimary
Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events
Showing all 5 trials